Volume 13, Number 4—April 2007
Research
Diagnosis of Tuberculosis by an Enzyme-Linked Immunospot Assay for Interferon-γ
Table 1
Characteristic | Value |
---|---|
Mean age, y (range) | 52.2 (2–84) |
Male:female (% male) | 37:28 (56.9) |
Underlying medical condition | 35 (53.8) |
Malignancy | 17 (26.2) |
Diabetes mellitus | 12 (18.5) |
Other† | 11 (16.9) |
Symptoms‡ | |
Cough or dyspnea [no. with hemoptysis] | 44 (67.7) [2] |
Fever | 35 (53.8) |
Mean duration of symptoms (range) | 23.4 wk (2 wk– 5 y) |
Radiographic finding | |
Upper lobe fibroexudative lesions [no. with cavitation] | 25 (38.5) [2] |
Multiple patches of alveolar infiltrates [no. with cavitation] | 20 (30.8) [1] |
Multiple nodules or mass [no. with cavitation] | 10 (15.4) [3] |
Upper lobe fibrotic change | 5 (7.7) |
Pleural effusion [no. with upper lobe fibrotic change] | 3 (4.6) [1] |
Miliary lesion | 2 (3.1) |
Acid-fast smear positive | 33 (50.8) |
Mycobacterial culture | 48 (73.8) |
Mycobacterium tuberculosis | 37 (56.9) |
M. avium-intracellulare complex | 2 (3.1) |
M. chelonae | 2 (3.1) |
M. abscessus and M. chelonae | 2 (3.1) |
M. abscessus | 1 (1.5) |
M. marinum | 1 (1.5) |
M. kansasii | 1 (1.5) |
Unidentified species | 2 (3.1) |
*Values are no. (%) unless otherwise indicated.
†Underlying disease was alcoholism in 4 patients, AIDS in 3 patients, end-stage renal disease in 2 patients, Sjogren syndrome in
1 patient, and hepatitis B-related liver cirrhosis in 1 patient.
‡Two patients were asymptomatic and had abnormal chest radiographs noted incidentally.
Page created: June 25, 2010
Page updated: June 25, 2010
Page reviewed: June 25, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.